<PAGE>
SECURITIES & EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
SCHEDULE 13G*
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
EP Medsystems Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
26881P103
(CUSIP Number)
September 1, 1999
(Date of event which requires filing of this statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule 13G is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
(Page 1 of 21 Pages)
- ----------------
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover
page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
<PAGE>
CUSIP No. 26881P103 13G Page 2 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
EGS Management, L.L.C.
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
202,152
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
202,152
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
202,152
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
2.0%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
OO
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 3 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
EGS Partners, L.L.C.
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
33,128
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
33,128
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
33,128
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.3%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
IA
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 4 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
The Pharmaceutical/Medical Technology Fund, L.P.
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
202,152
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
202,152
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
202,152
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
2.0%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
PN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 5 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
Strategic Healthcare Investment Fund
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
33,128
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
33,128
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
33,128
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.3%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
PN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 6 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
EGS Private Healthcare Associates, LLC
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
1,000,000
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
1,000,000
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,000,000
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
10.1%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
OO
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 7 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
EGS Private Healthcare Partnership, L.P.
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
875,000
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
875,000
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
875,000
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
8.9%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
PN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 8 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
EGS Private Healthcare Counterpart, L.P.
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
125,000
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
125,000
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
125,000
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
1.3%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
PN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 9 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
William Ehrman
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
1,235,280
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
1,235,280
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,235,280
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
12.5%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
IN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 10 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
Frederic Greenberg
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
1,235,280
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
1,235,280
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,235,280
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
12.5%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
IN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 11 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
Frederick Ketcher
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
1,235,280
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
1,235,280
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,235,280
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
12.5%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
IN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 12 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
Jonas Gerstl
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
1,235,280
OWNED BY
______________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
1,235,280
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,235,280
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
12.5%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
IN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 13 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
William D. Lautman
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
1,235,280
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
1,235,280
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,235,280
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
12.5%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
IN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 14 of 21 Pages
________________________________________________________________________
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO.
OF ABOVE PERSONS (ENTITIES ONLY)
James McLaren
________________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [ ]
(b) [X]
________________________________________________________________________
(3) SEC USE ONLY
________________________________________________________________________
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________
NUMBER OF (5) SOLE VOTING POWER
-0-
SHARES
______________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
1,000,000
OWNED BY
___________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
-0-
REPORTING
______________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
1,000,000
________________________________________________________________________
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,000,000
________________________________________________________________________
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ]
________________________________________________________________________
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
10.1%
________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
IN
________________________________________________________________________
** SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 26881P103 13G Page 15 of 21 Pages
Item 1(a). Name of Issuer:
The name of the issuer is EP Medsystems Inc. (the "Company").
Item 1(b). Address of Issuer's Principal Executive Offices:
The Company's principal executive offices are located at 100 Stierli
Court, Mount Arlington, New Jersey 07856.
Item 2(a). Name of Persons Filing:
This statement is filed by:
(i) EGS Management, L.L.C., a Delaware limited liability
company ("EGS Management"), with respect to Shares beneficially owned by
The Pharmaceutical/Medical Technology Fund, L.P.;
(ii) EGS Partners, L.L.C., a Delaware limited liability
company ("EGS Partners"), with respect to shares of Common Stock
beneficially owned by Strategic Healthcare Investment Fund, a Cayman
Islands company;
(iii) The Pharmaceutical/Medical Technology Fund, L.P., a
Delaware limited partnership ("Pharm/Med Tech Fund"), with respect to
Shares beneficially owned by it;
(iv) Strategic Healthcare Investment Fund, a Cayman Islands
company ("Strategic Healthcare"), with respect to Shares beneficially
owned by it;
(v) EGS Private Healthcare Associates, LLC, a Delaware
limited liability company ("Healthcare Associates"), with respect to
Shares beneficially owned by EGS Private Healthcare Partnership, L.P.
and EGS Private Healthcare Counterpart, L.P.;
(vi) EGS Private Healthcare Partnership, L.P., a Delaware
limited partnership ("Healthcare Partnership"), with respect to Shares
beneficially owned by it;
(vii) EGS Private Healthcare Counterpart, L.P., a Delaware
limited partnership ("Healthcare Counterpart"), with respect to Shares
beneficially owned by it;
(viii) William Ehrman, with respect to Shares beneficially
owned by Pharm/Med Tech Fund, Strategic Healthcare, Healthcare
Partnership and Healthcare Counterpart;
(ix) Frederic Greenberg, with respect to Shares beneficially
owned by Pharm/Med Tech Fund, Strategic Healthcare, Healthcare
Partnership and Healthcare Counterpart;
(x) Frederick Ketcher, with respect to Shares beneficially
owned by Pharm/Med Tech Fund, Strategic Healthcare, Healthcare
Partnership and Healthcare Counterpart;
(xi) Jonas Gerstl, with respect to Shares beneficially owned
by Pharm/Med Tech Fund, Strategic Healthcare, Healthcare Partnership and
Healthcare Counterpart;
(xii) William Lautman, with respect to Shares beneficially
owned by Pharm/Med Tech Fund, Strategic Healthcare, Healthcare
Partnership and Healthcare Counterpart; and
(xiii) James McLaren, with respect to Shares beneficially
owned by Healthcare Partnership and Healthcare Counterpart.
The foregoing persons hereinafter sometimes are referred to
collectively as the "Reporting Persons." Any disclosures herein with
respect to persons other than the Reporting Persons are made on
information and belief after making inquiry to the appropriate party.
<PAGE>
CUSIP No. 26881P103 13G Page 16 of 21 Pages
The members of EGS Management and EGS Partners are William Ehrman,
Frederic Greenberg, Frederick Ketcher, Jonas Gerstl and William Lautman.
The members of Healthcare Associates are William Ehrman, Frederic
Greenberg, Frederick Ketcher, Jonas Gerstl, William Lautman and James
McLaren (collectively, the "Members").
Item 2(b). Address of Principal Business Office or, if None,
Residence:
The address of the principal business and principal office of (i)
EGS Management, EGS Partners, Healthcare Associates, Pharm/Med Tech
Fund, Healthcare Partnership, Healthcare Counterpart and each of the
Members, is 350 Park Avenue, 11th Floor, New York, New York 10022 and
(ii) Strategic Healthcare is c/o MeesPierson (Cayman) Limited, British
American Centre, Phase 3, Dr. Roy's Drive, P.O. Box 2003, George Town,
Grand Cayman, Cayman Islands, B.W.I.
Item 2(c). Citizenship:
Each of the individuals referred to in paragraph (a) above is a
United States citizen. EGS Management, EGS Partners and Healthcare
Associates are Delaware limited liability companies. Pharm/Med Tech
Fund, Healthcare Partnership and Healthcare Counterpart are Delaware
limited partnerships. Strategic Healthcare is a company formed in the
Cayman Islands.
Item 2(d). Title of Class of Securities:
Common stock
Item 2(e). CUSIP Number:
26881P1O3
Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-
2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under Section 15 of the
Act,
(b) [ ] Bank as defined in Section 3(a)(6) of the Act,
(c) [ ] Insurance Company as defined in Section 3(a)(19) of
the Act,
(d) [ ] Investment Company registered under Section 8 of the
Investment Company Act of 1940,
(e) [ ] Investment Adviser in accordance with Rule
13d-1 (b)(1)(ii)(E),
(f) [ ] Employee Benefit Plan or Endowment Fund in
accordance with 13d-1 (b)(1)(ii)(F),
(g) [ ] Parent Holding Company or control person in
accordance with Rule 13d-1 (b)(1)(ii)(G),
<PAGE>
CUSIP No. 26881P103 13G Page 17 of 21 Pages
(h) [ ] Savings Association as defined in Section 3(b) of
the Federal Deposit Insurance Act,
(i) [ ] Church Plan that is excluded from the definition of
an investment company under Section 3(c)(14) of the
Investment Company Act of 1940,
(j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to 13d-1(c), check this box:
[x]
Item 4. Ownership.
As of the close of business on September 1, 1999:
A. EGS Management, L.L.C.
(a) Amount beneficially owned: 202,152
(b) Percent of class: 2.0% The percentages used herein and
in the rest of Item 4 are calculated based upon the 9,875,417 Shares
issued and outstanding as of August 12, 1999 as reported on the
Company's quarterly report on Form 10-Q filed with the Securities and
Exchange Commission by the Company for the quarter ended June 30, 1999.
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 202,152
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
202,152
B. EGS Partners, L.L.C.
(a) Amount beneficially owned: 33,128
(b) Percent of class: 0.3%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 33,128
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
33,128
C. Pharm/Med Tech Fund
(a) Amount beneficially owned: 202,152
(b) Percent of class: 2.0%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 202,152
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
202,152
D. Strategic Healthcare
(a) Amount beneficially owned: 33,128
(b) Percent of class: 0.3%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 33,128
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
33,128
<PAGE>
CUSIP No. 26881P103 13G Page 18 of 21 Pages
E. Healthcare Associates
(a) Amount beneficially owned: 1,000,000
(b) Percent of class: 10.1%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 1,000,000
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
1,000,000
F. Healthcare Partnership
(a) Amount beneficially owned: 875,000
(b) Percent of class: 8.9%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 875,000
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
875,000
G. Healthcare Counterpart
(a) Amount beneficially owned: 125,000
(b) Percent of class: 1.3%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 125,000
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
125,000
H. William Ehrman
(a) Amount beneficially owned: 1,235,280
(b) Percent of class: 12.5%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 1,235,280
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
1,235,280
I. Frederic Greenberg
(a) Amount beneficially owned: 1,235,280
(b) Percent of class: 12.5%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 1,235,280
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
1,235,280
J. Frederick Ketcher
(a) Amount beneficially owned: 1,235,280
(b) Percent of class: 12.5%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 1,235,280
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
1,235,280
<PAGE>
CUSIP No. 26881P103 13G Page 19 of 21 Pages
K. Jonas Gerstl
(a) Amount beneficially owned: 1,235,280
(b) Percent of class: 12.5%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 1,235,280
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
1,235,280
L. William D. Lautman
(a) Amount beneficially owned: 1,235,280
(b) Percent of class: 12.5%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 1,235,280
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
1,235,280
M. James McLaren
(a) Amount beneficially owned: 1,000,000
(b) Percent of class: 10.1%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 1,000,000
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
1,000,000
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
To the knowledge of the Reporting Persons, no other person has the
right to receive or the power to direct the receipt of dividends from,
or the proceeds from the sale of, a number of such Common Stock which
represents more than five percent of the number of outstanding shares of
Common Stock.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
<PAGE>
CUSIP No. 26881P103 13G Page 20 of 21 Pages
Item 10. Certification.
Each of the Reporting Persons hereby makes the following
certification:
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in any
transaction having that purpose or effect.
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief,
the undersigned certify that the information set forth in this statement
is true, complete and correct.
DATED: November 4, 1999
/s/ William Ehrman
----------------------------------
William Ehrman, individually, as a
member of EGS Management, L.L.C.,
EGS Partners, L.L.C. and EGS Private
Healthcare Associates, LLC, as a member of
EGS Management, L.L.C. on behalf of The
Pharmaceutical/Medical Technology Fund,
L.P., as a member of EGS Partners, L.L.C. on
behalf of Strategic Healthcare Investment
Fund and as member of EGS Private Healthcare
Associates, LLC on behalf of EGS Private
Healthcare Partnership, L.P. and EGS Private
Healthcare Counterpart, L.P.
/s/ Frederic Greenberg
--------------------------------
Frederic Greenberg, individually
/s/ Frederick Ketcher
--------------------------------
Frederick Ketcher, individually
/s/ Jonas Gerstl
--------------------------------
Jonas Gerstl, individually
/s/ William D. Lautman
--------------------------------
William D. Lautman, individually
<PAGE>
CUSIP No. 26881P103 13G Page 21 of 21 Pages
/s/ James McLaren
--------------------------------
James McLaren, individually
